Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 14, 2021; 27(38): 6465-6475
Published online Oct 14, 2021. doi: 10.3748/wjg.v27.i38.6465
Published online Oct 14, 2021. doi: 10.3748/wjg.v27.i38.6465
General characteristics | non-DR, n = 53 | DR, n = 49 | P value |
Demographics | |||
Gender (female/male) | 28/25 | 17/32 | 0.065 |
Age (mean ± SD) | 63.3 ± 11.1/63.2 ± 7.5 | 58.6 ± 11.2/59.7 ± 14.1 | 0.117 |
Tumor markers | |||
AFP (normal/abnormal) | 51/2 | 47/2 | 0.936 |
CEA (normal/abnormal) | 14/39 | 14/35 | 0.807 |
CA19-9 (normal/abnormal) | 30/23 | 18/31 | 0.045 |
Clinical T/N staging | |||
T1/T2/T3/T4 | 0/1/48/4 | 0/10/33/6 | 0.136 |
N0/N1/N2 | 3/28/22 | 5/8/36 | 0.030 |
Sequence | Training set | P value | Validation set | P value |
Ra-DWI | 0.652 (95%CI, 0.571-0.726) | 0.001 | 0.661 (95%CI, 0.536-0.772) | 0.018 |
Ra-T2WI | 0.628 (95%CI, 0.547-0.704) | 0.005 | 0.575 (95%CI, 0.450-0.695) | 0.291 |
Ra-CEPP | 0.633 (95%CI, 0.552-0.709) | 0.003 | 0.543 (95%CI, 0.418-0.664) | 0.544 |
- Citation: Ma YQ, Wen Y, Liang H, Zhong JG, Pang PP. Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer. World J Gastroenterol 2021; 27(38): 6465-6475
- URL: https://www.wjgnet.com/1007-9327/full/v27/i38/6465.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i38.6465